Inhibikase Therapeutics, Inc.

Rachunek Zysków i Strat





index 0 1 2 3 4 5 6 7 8
Rok finansowy 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 1 2 4 1 1 3 0 0 0
Przychód Δ r/r 0.0% 113.0% 96.1% -72.2% -37.8% 343.9% -96.0% 111.0% -100.0%
Marża brutto 12.5% 14.8% 100.0% -127.4% -28.0% -266.4% 94.6% 31.9% 0.0%
EBIT (mln) -1 -0 -2 -6 -3 -15 -18 -20 -29
EBIT Δ r/r 0.0% -33.9% 423.8% 168.5% -50.5% 423.9% 22.8% 10.8% 42.3%
EBIT (%) -63.4% -19.7% -52.5% -507.5% -403.5% -476.2% -14686.2% -7712.0% nan
Koszty finansowe (mln) 0 0 0 0 0 0 0 0 0
EBITDA (mln) 0 0 -2 -6 -3 -15 -18 -20 -29
EBITDA(%) -1.6% -19.7% -52.5% -507.5% -403.5% -476.2% -14680.7% -7643.9% nan
Podatek (mln) -0 -0 0 0 0 0 -0 0 0
Zysk Netto (mln) -1 -0 -2 -6 -3 -15 -18 -19 -28
Zysk netto Δ r/r 0.0% -30.6% 393.6% 167.0% -49.9% 414.6% 20.9% 6.3% 44.6%
Zysk netto (%) -65.0% -21.2% -53.3% -511.9% -411.9% -477.5% -14505.2% -7304.8% nan
EPS -0.48 -0.25 -1.61 -3.34 -1.72 -4.88 -4.26 -3.57 -1.16
EPS (rozwodnione) -0.48 -0.25 -1.61 -3.34 -1.72 -4.88 -4.26 -3.57 -1.16
Ilośc akcji (mln) 1 2 1 2 2 3 4 5 24
Ważona ilośc akcji (mln) 1 2 1 2 2 3 4 5 24
Waluta USD USD USD USD USD USD USD USD USD